The Trump administration has announced an additional $250 million in aid to the Philippines, aimed at combating tuberculosis, improving maternal health, and addressing emerging disease threats. U.S. Secretary of State Marco Rubio revealed the funding on Thursday, highlighting the initiative as part of President Donald Trump’s new foreign aid strategy.
This announcement follows the $63 million commitment made during Trump’s meeting with Philippine President Ferdinand Marcos Jr. at the White House in July. Rubio emphasized that the aid reflects the “comprehensive bond between the United States and the Philippines” and showcases a more “efficient, time-limited, and narrowly targeted” America First approach to foreign assistance.
The Philippine embassy in Washington expressed appreciation for the aid but offered no further comments. The pledge underscores Washington’s continued strategic interest in strengthening bilateral ties with Manila while shifting away from traditional aid models such as USAID.
The Trump administration has consistently sought to reduce foreign assistance, attempting to withhold billions of dollars allocated by Congress as part of its broader “America First” policy. Despite these efforts, lawmakers, led by Republicans, have set aside billions in foreign aid funding, including $11 billion that must be allocated before the September 30 deadline.
After facing lawsuits, the administration agreed to release $6.5 billion in aid but continues to fight in court to block another $4 billion. The dispute is currently under review by the U.S. Supreme Court.
The latest pledge to the Philippines highlights Trump’s direct aid strategy, which prioritizes targeted investments in key areas while scaling back traditional multilateral pipelines. As Washington redefines its foreign assistance framework, the Philippines emerges as a key partner in regional health and security cooperation.


RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
US Reaffirms Taiwan Arms Sales Policy Despite Trump’s Comments on China
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
US Urges States and Businesses to Strengthen Taiwan Ties Amid China Pressure
Bessent Says U.S. Must Strengthen Supply Chains and Economic Security
Trump Administration Rejects Claims of Rift Between JD Vance and Marco Rubio on Iran Policy
Why the future of marijuana legalization remains hazy despite high public support
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Cait Conley Wins Democratic Nomination, Sets Up Key House Battle Against Mike Lawler in New York 



